Androgenic alopecia; the risk–benefit ratio of Finasteride
Finasteride is currently approved and largely used as a therapeutic option for androgenetic alopecia. Apparently a safe drug and effective at the onset, several concerns appeared over time regarding the frequency and magnitude of finasteride adverse effects, which in some cases seem to be even irrev...
Saved in:
| Main Authors: | David L. Rowland, Ion G. Motofei, Ioana Păunică, Petrișor Banu, Mihaela F. Nistor, Stana Păunică, Vlad D. Constantin |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2018-04-01
|
| Series: | Journal of Mind and Medical Sciences |
| Subjects: | |
| Online Access: | https://scholar.valpo.edu/cgi/viewcontent.cgi?article=1113&context=jmms |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Finasteride Side Effects and Post-Finasteride Syndrome in Male Androgenic Alopecia
by: Manea Mirela, et al.
Published: (2015-10-01) -
Finasteride adverse effects and post-finasteride syndrome; implications for dentists
by: Stana Paunica, et al.
Published: (2016-04-01) -
The postfinasteride syndrome; an overview
by: David L. Rowland, et al.
Published: (2016-10-01) -
Male androgenetic alopecia
by: Gabriel Lazzeri Cortez, et al.
Published: (2025-04-01) -
Unlocking finasteride's potential via carboxymethyl-β-cyclodextrin inclusion complex for androgenic alopecia
by: Reza Allahyari, et al.
Published: (2025-06-01)